Internal Medicine, Pulmonary Disease · Peoria, AZ
NPI
1508854787
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13634 North 93rd Avenue, Suite 100
Peoria, AZ, 85381
Phone (623) 933-0301
Groups this clinician bills Medicare through
Medicare paid, 2024
$184K
2,959 services
Medicare patients, 2024
612
Average age 77
Drug cost, 2024
$2.0M
3,934 prescriptions
Company payments, 2025
$2,504
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Girish H Mehta was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 769 times for 445 patients. In total Girish H Mehta billed 2,959 services in 20 codes, and Medicare paid $184K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 769 | 445 | $13.14 | $10K |
| 99214 Office E&M - Established | Office | 539 | 360 | $94.78 | $51K |
| 99215 Office E&M - Established | Office | 434 | 288 | $144.33 | $63K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 241 | 41 | $0.74 | $179 |
| 94729 Pulmonary Function Testing | Office | 186 | 173 | $43.85 | $8,156 |
| 94726 Pulmonary Function Testing | Office | 171 | 163 | $43.40 | $7,422 |
| 94060 Pulmonary Function Testing | Office | 158 | 150 | $30.44 | $4,810 |
| 99205 Office E&M - New | Office | 151 | 151 | $169.42 | $26K |
| 94010 Pulmonary Function Testing | Office | 78 | 74 | $21.08 | $1,645 |
| 99204 Office E&M - New | Office | 56 | 56 | $131.18 | $7,346 |
| 96372 Injection Administration | Office | 48 | 42 | $11.07 | $532 |
| 94375 Pulmonary Function Testing | Office | 41 | 39 | $30.65 | $1,257 |
| 99406 Behavioral Health Services | Office | 29 | 21 | $14.30 | $415 |
| 94618 Pulmonary Function Testing | Office | 21 | 21 | $27.47 | $577 |
| 94664 E&M - Miscellaneous | Office | 15 | 14 | $14.38 | $216 |
By year: 2022 $110K for 1,721 services; 2023 $106K for 1,580 services; 2024 $184K for 2,959 services.
Medicare prescription drug claims, 2024
In 2024, the drug Girish H Mehta prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 622 prescriptions and refills. In total Girish H Mehta wrote 3,934 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 622 | 1,080 | 165 | $666K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 532 | 927 | 245 | $24K |
| Fluticasone Propionate Generic | 290 | 611 | 151 | $5,687 |
| Prednisone Generic | 282 | 519 | 162 | $1,332 |
| Azithromycin Generic | 217 | 446 | 108 | $2,337 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 199 | 426 | 68 | $48K |
| Montelukast Sodium Generic | 181 | 524 | 61 | $2,096 |
| Ipratropium Bromide Generic | 168 | 285 | 86 | $7,211 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 94 | 182 | 24 | $81K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 79 | 141 | 25 | $17K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 75 | 131 | 17 | $62K |
| Breo Ellipta Fluticasone/Vilanterol | 74 | 126 | 16 | $48K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 68 | 132 | 31 | $81K |
| Fluconazole Generic | 68 | 166 | 29 | $12K |
| Spiriva Respimat Tiotropium Bromide | 67 | 149 | 23 | $77K |
Brand drugs: 1,628 claims; generic drugs: 2,306 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Girish H Mehta $2,504 ($2,504 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $510.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $510 |
| Genzyme Corporation SNY | 10 | $292 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $289 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $198 |
| Electromed, Inc. ELMD | 15 | $180 |
| Merck Sharp & Dohme LLC MRK | 6 | $156 |
| Insmed, Inc. INSM | 12 | $147 |
| GlaxoSmithKline, LLC. GSK | 11 | $142 |
| Baxter Healthcare BAX | 6 | $125 |
| Viatris Specialty LLC | 4 | $99.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.